Craif selected as a finalist in the WIPO Global Awards 2026, hosted by the UN's WIPO.
Bio-AI startup Craif has been selected as a finalist in the WIPO Global Awards 2026, hosted by the UN's World Intellectual Property Organization. Their development of early cancer detection technology using urinary microRNA analysis and their use of intellectual property were highly evaluated.
📋 Article Processing Timeline
- 📰 Published: May 28, 2026 at 09:00
- 🔍 Collected: June 1, 2026 at 00:49 (87h 49m after Published)
- 🤖 AI Analyzed: June 1, 2026 at 23:52 (23h 3m after Collected)
Bio-AI startup Craif Inc. (CEO: Ryuichi Onose) has been selected as one of the 33 finalists in the WIPO Global Awards 2026, hosted by the United Nations' World Intellectual Property Organization (WIPO), out of 1,300 applications from 126 countries. The company was recognized for its development and commercialization of technology enabling early cancer detection through the extraction, measurement, and analysis of urinary microRNA, as well as its acquisition and utilization of patents in the healthcare and biotechnology fields. The WIPO Global Awards recognize outstanding companies that use intellectual property to bring positive impact globally. Craif will continue to challenge itself to realize its mission of 'a society where people can live out their natural lifespans' by delivering new initiatives for early cancer detection and prevention.
FAQ
Where can I find details about Craif?
You can check their official website at https://craif.com/.